The outlook on the prevention, diagnosis and treatment of Alzheimer’s disease is brighter than ever. Backed by decades of research, the field is beginning to see tangible success in moving basic biological insights into actual diagnostics and therapeutics.
Articles in this report were published editorially independently. The collection was made possible by the support of Eisai.
smartboy10/Getty Images
Controversial New Guidelines Would Diagnose Alzheimer’s before Symptoms Appear
According to expert recommendations, the diagnosis of Alzheimer’s can proceed by detecting the disease’s underlying biology—even before the onset of cognitive decline
Newly Recognized Dementia Called LATE May Hit 40 Percent of Older People
The pathological buildup of a protein known as TDP-43 can lead to an Alzheimer’s-like disorder
Annual U.S. Dementia Cases Projected to Rise to 1 Million by 2060
A new study finds that dementia cases will increase at a much higher rate than expected, with lifetime risk rising to 42 percent after age 55
Shingles Vaccination May Help Protect People from Alzheimer’s Disease
A natural experiment in Wales showed that a shingles vaccine might lower the risk of developing dementia
Time Spent in Nature Can Be Good—And Sometimes Bad—For Your Brain
A “Goldilocks” measure of green space might help stave off dementia, but an excess could lead to cognitive decline
Should You Get a Blood Test For Alzheimer’s?
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much—yet.
A Neurologist Answers Questions Patients Might Have about the New Alzheimer’s Drug Lecanemab
What a patient and family members can expect from the recently approved drug lecanemab—and what more is needed to help stop Alzheimer’s dementia